Jade Biosciences to Participate in Upcoming Investor ConferencesVANCOUVER, British Columbia and SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Jade Biosciences (“Jade”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that the company will participate in two upcoming investor conferences in November 2024.
Aerovate Therapeutics and Jade Biosciences Announce Merger AgreementMerger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases
